Additionally, androgen treatment stimulated Akt and PI3K activation via AR- and proto-oncogene tyrosine protein kinase (Src)-dependent mechanisms within prostate and breast cancer cell lines [123–126]. This evidence concerns the gene AR and breast cancer.